Investor Relations

FAQ

  • What is Boston Therapeutics, Inc.'s stock symbol?
  • Our stock is traded on the OTCQB under the symbol BTHE.

  • Can I buy stock directly from Boston Therapeutics, Inc.?
  • No, You will need to contact a licensed stock broker or use an online trading account.

  • How can I buy stock in Boston Therapeutics, Inc.?
  • Through a licensed stock broker or by using an online trading account.

  • How do I change the address on my shareholder account?
  • Through your brokerage account or by contacting our transfer agent.

  • When was Boston Therapeutics, Inc. incorporated?
  • August 2009

  • When did Boston Therapeutics, Inc. become a public company?
  • October 2010

  • Where is Boston Therapeutics, Inc. located?
  • 1750 Elm Street
    Suite 103
    Manchester, NH 03104

  • When is Boston Therapeutics, Inc.'s fiscal year end?
  • December 31st

  • Who is Boston Therapeutics, Inc.'s transfer agent?
  • Worldwide Stock Transfer, LLC
    Yonah Kopstick
    433 Hackensack Avenue
    Level L
    Hackensack, NJ 07601
    (210) 820-2008
    www.wwstr.com

  • Who are Boston Therapeutics, Inc.'s independent auditors?
  • McGladrey, LLP
    80 City Square
    Boston, MA 02129

  • Who is Boston Therapeutics, Inc.'s outside legal counsel?
  • Seyfarth Shaw LLP
    Two Seaport Lane
    Boston, MA 02210

  • Whom can I contact for general information about Boston Therapeutics, Inc.?
  • Boston Therapeutics, Inc.
    Anthony Squeglia
    Director of Strategic Planning and Investor Relations
    1750 Elm Street
    Suite 103
    Manchester, NH 03104
    (603) 935-9799
    (603) 685-4784 fax
    anthony.squeglia@bostonti.com